ClinicalTrials.Veeva

Menu

A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Bristol-Myers Squibb (BMS) logo

Bristol-Myers Squibb (BMS)

Status

Completed

Conditions

Carcinoma, Non-Small-Cell Lung

Study type

Observational

Funder types

Industry

Identifiers

NCT05250817
CA209-69K

Details and patient eligibility

About

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

Enrollment

501 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

The following is the inclusion criteria for pretest interviews and final online survey.

Participants:

  • Must be 18 years of age or older
  • Must be a US resident.
  • Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

Exclusion criteria

  • Not applicable

Other protocol-defined inclusion/exclusion criteria apply

Trial design

501 participants in 2 patient groups

Cohort 1
Description:
Participants with early stage and advanced/metastatic non-small cell lung cancer (NSCLC)
Cohort 2
Description:
Participants from the general population

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems